| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 306.15B | 299.29B | 311.55B | 307.70B | 329.39B | 284.10B |
| Gross Profit | 40.72B | 41.12B | 40.52B | 38.73B | 37.06B | 30.65B |
| EBITDA | 15.62B | 15.04B | 16.46B | 16.13B | 13.87B | 10.56B |
| Net Income | 10.01B | 12.01B | 11.66B | 9.62B | 8.12B | 6.81B |
Balance Sheet | ||||||
| Total Assets | 139.95B | 153.37B | 146.08B | 143.35B | 143.20B | 134.12B |
| Cash, Cash Equivalents and Short-Term Investments | 21.77B | 29.54B | 23.81B | 21.46B | 18.96B | 12.24B |
| Total Debt | 1.58B | 469.00M | 1.66B | 3.15B | 5.43B | 5.50B |
| Total Liabilities | 48.39B | 50.93B | 53.97B | 61.25B | 71.04B | 69.02B |
| Stockholders Equity | 91.48B | 102.33B | 92.01B | 82.06B | 72.16B | 65.06B |
Cash Flow | ||||||
| Free Cash Flow | 926.50M | 10.99B | 6.40B | 9.45B | 9.51B | -2.41B |
| Operating Cash Flow | 1.03B | 11.54B | 7.14B | 9.69B | 9.60B | -2.33B |
| Investing Cash Flow | 93.50M | -1.82B | -1.03B | -2.71B | -261.00M | 197.00M |
| Financing Cash Flow | -1.07B | -5.01B | -4.78B | -5.38B | -3.10B | -4.01B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥343.09B | 7.92 | 11.34% | 3.38% | 2.99% | 0.84% | |
75 Outperform | ¥151.47B | 9.78 | ― | 2.66% | -4.09% | 57.12% | |
73 Outperform | ¥102.74B | 8.61 | ― | 3.74% | -3.93% | 3.02% | |
73 Outperform | ¥362.83B | 9.25 | ― | 3.13% | 1.46% | 24.34% | |
65 Neutral | ¥315.92B | 14.72 | 8.35% | 2.73% | 1.53% | 43.13% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | ¥1.19T | 7.20 | 11.17% | 3.24% | 9.87% | -3.76% |